Cargando…

Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson’s and Alzheimer’s Disease Therapy

Deep brain stimulation (DBS) is a surgical procedure that uses electrical neuromodulation to target specific regions of the brain, showing potential in the treatment of neurodegenerative disorders such as Parkinson’s disease (PD) and Alzheimer’s disease (AD). Despite similarities in disease patholog...

Descripción completa

Detalles Bibliográficos
Autores principales: Senevirathne, Degiri Kalana Lasanga, Mahboob, Anns, Zhai, Kevin, Paul, Pradipta, Kammen, Alexandra, Lee, Darrin Jason, Yousef, Mohammad S., Chaari, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252401/
https://www.ncbi.nlm.nih.gov/pubmed/37296599
http://dx.doi.org/10.3390/cells12111478
_version_ 1785056162460205056
author Senevirathne, Degiri Kalana Lasanga
Mahboob, Anns
Zhai, Kevin
Paul, Pradipta
Kammen, Alexandra
Lee, Darrin Jason
Yousef, Mohammad S.
Chaari, Ali
author_facet Senevirathne, Degiri Kalana Lasanga
Mahboob, Anns
Zhai, Kevin
Paul, Pradipta
Kammen, Alexandra
Lee, Darrin Jason
Yousef, Mohammad S.
Chaari, Ali
author_sort Senevirathne, Degiri Kalana Lasanga
collection PubMed
description Deep brain stimulation (DBS) is a surgical procedure that uses electrical neuromodulation to target specific regions of the brain, showing potential in the treatment of neurodegenerative disorders such as Parkinson’s disease (PD) and Alzheimer’s disease (AD). Despite similarities in disease pathology, DBS is currently only approved for use in PD patients, with limited literature on its effectiveness in AD. While DBS has shown promise in ameliorating brain circuits in PD, further research is needed to determine the optimal parameters for DBS and address any potential side effects. This review emphasizes the need for foundational and clinical research on DBS in different brain regions to treat AD and recommends the development of a classification system for adverse effects. Furthermore, this review suggests the use of either a low-frequency system (LFS) or high-frequency system (HFS) depending on the specific symptoms of the patient for both PD and AD.
format Online
Article
Text
id pubmed-10252401
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102524012023-06-10 Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson’s and Alzheimer’s Disease Therapy Senevirathne, Degiri Kalana Lasanga Mahboob, Anns Zhai, Kevin Paul, Pradipta Kammen, Alexandra Lee, Darrin Jason Yousef, Mohammad S. Chaari, Ali Cells Review Deep brain stimulation (DBS) is a surgical procedure that uses electrical neuromodulation to target specific regions of the brain, showing potential in the treatment of neurodegenerative disorders such as Parkinson’s disease (PD) and Alzheimer’s disease (AD). Despite similarities in disease pathology, DBS is currently only approved for use in PD patients, with limited literature on its effectiveness in AD. While DBS has shown promise in ameliorating brain circuits in PD, further research is needed to determine the optimal parameters for DBS and address any potential side effects. This review emphasizes the need for foundational and clinical research on DBS in different brain regions to treat AD and recommends the development of a classification system for adverse effects. Furthermore, this review suggests the use of either a low-frequency system (LFS) or high-frequency system (HFS) depending on the specific symptoms of the patient for both PD and AD. MDPI 2023-05-25 /pmc/articles/PMC10252401/ /pubmed/37296599 http://dx.doi.org/10.3390/cells12111478 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Senevirathne, Degiri Kalana Lasanga
Mahboob, Anns
Zhai, Kevin
Paul, Pradipta
Kammen, Alexandra
Lee, Darrin Jason
Yousef, Mohammad S.
Chaari, Ali
Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson’s and Alzheimer’s Disease Therapy
title Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson’s and Alzheimer’s Disease Therapy
title_full Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson’s and Alzheimer’s Disease Therapy
title_fullStr Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson’s and Alzheimer’s Disease Therapy
title_full_unstemmed Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson’s and Alzheimer’s Disease Therapy
title_short Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson’s and Alzheimer’s Disease Therapy
title_sort deep brain stimulation beyond the clinic: navigating the future of parkinson’s and alzheimer’s disease therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252401/
https://www.ncbi.nlm.nih.gov/pubmed/37296599
http://dx.doi.org/10.3390/cells12111478
work_keys_str_mv AT senevirathnedegirikalanalasanga deepbrainstimulationbeyondtheclinicnavigatingthefutureofparkinsonsandalzheimersdiseasetherapy
AT mahboobanns deepbrainstimulationbeyondtheclinicnavigatingthefutureofparkinsonsandalzheimersdiseasetherapy
AT zhaikevin deepbrainstimulationbeyondtheclinicnavigatingthefutureofparkinsonsandalzheimersdiseasetherapy
AT paulpradipta deepbrainstimulationbeyondtheclinicnavigatingthefutureofparkinsonsandalzheimersdiseasetherapy
AT kammenalexandra deepbrainstimulationbeyondtheclinicnavigatingthefutureofparkinsonsandalzheimersdiseasetherapy
AT leedarrinjason deepbrainstimulationbeyondtheclinicnavigatingthefutureofparkinsonsandalzheimersdiseasetherapy
AT yousefmohammads deepbrainstimulationbeyondtheclinicnavigatingthefutureofparkinsonsandalzheimersdiseasetherapy
AT chaariali deepbrainstimulationbeyondtheclinicnavigatingthefutureofparkinsonsandalzheimersdiseasetherapy